Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Fudan University

Latest From Fudan University

Pfizer Pilot Aims Local To Help China Kick Smoking Habit

Innovative drug makers are resorting to patient assistance and commercial insurance programs for their high-priced therapies in China. Pfizer is test-driving a new approach for its smoking cessation drug.

BioPharmaceutical China

Life Science Start-Ups: Tech Transfer Deals, July-August 2014

Derived from Strategic Transactions, a fully searchable premium source for tracking life sciences deal activity, the Tech Transfer Deals column provides a monthly update on technology transfer deals, reporting licensing agreements between companies and universities or other research institutions within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced May through June 2014.

BioPharmaceutical Medical Device

China’s NDRC Launches National Lab To Research Therapeutic Vaccines

China’s NDRC launched a national engineering lab for therapeutic vaccines on June 7 at Fudan University, with the first planned effort of research a therapeutic vaccine for Hepatitis B.

BioPharmaceutical China

AstraZeneca Goes Deeper Into China Cardiovascular Focus With Tianjin Medical University Agreement

AstraZeneca has signed a collaboration agreement with Chinese research institution Tianjin Medical University to co-explore novel targets against cardiac fibrosis. The agreement builds on a string of such academic collaborations in the country focused on growing chronic diseases.

BioPharmaceutical China
See All